High Court's Ruling on DNA Could Boost Biotech

An unusual unanimous Supreme Court decision Thursday barred patents on naturally occurring DNA, but analysts said the ruling appeared to do little if any harm to biotech companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.